Autologous CAR-T Cell Manufacturing: Current Standing and Future Directions
A Look at What Drug Manufacturers are Likely Using to Make CAR-T Products
Supplement: MilliporeSigma Sees Opportunity in Continuous Processing
From the GEN Sounds of Science Podcast
Why CAR-T Therapies Don’t Work for Everyone Yet
Selecting the Best Type of T Cells for CAR-T May be Key to the Overall Efficacy of the Therapies
Cell-Centered: Scientists Embrace Cell-Replacement Therapy for Type 1 Diabetes
Forming Beta Cells from Stem Cells
For full access to this article login to GEN Select now.
Tips on How to Make Good Cells Better
Cell-Line Optimization Takes Many Forms, and Each Approach Has Its Adherents
- While cell-service companies may argue persuasively for their pet technologies, cell-line optimization can proceed from several different angles. Andrew Sandford, vp of business development at Selexis, describes his company as a “pure-play developer of technologies for rapidly producing stable, high-performing cell lines for bioproduction.” The company’s rapid ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.